Updated: Troubled Emergent claims J&J will owe up to $420M if it pulls the plug on its Covid-19 vaccine
Embattled contract manufacturer Emergent BioSolutions, which trashed tens of millions of J&J’s Covid-19 vaccine doses because of its contaminated Baltimore plant, is now telling J&J that it will have to pay somewhere in the range of $125 million to $420 million if it terminates its Covid manufacturing contract with Emergent.
In an SEC filing Monday, Emergent said that it provided Janssen with “a notice of material breach” because Janssen is essentially winding down its Covid-19 vaccine operations before fulfilling the minimum requirements in its contract with Emergent.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.